Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 4—April 2012
CME ACTIVITY - Research

Determinants for Autopsy after Unexplained Deaths Possibly Resulting from Infectious Causes, United States

Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Cite This Article

Introduction

CME Logo

MEDSCAPE CME

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.

Release date: March 15, 2012; Expiration date: March 15, 2013

Learning Objectives

Upon completion of this activity, participants will be able to:

•     Assess characteristics of cases of unexplained deaths possibly resulting from infectious causes

•     Distinguish the age group most likely to receive an autopsy after unexplained death

•     Evaluate other variables associated with a higher likelihood of receiving an autopsy after unexplained death

CME Editor

Karen L. Foster, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Karen L. Foster has disclosed no relevant financial relationships.

CME AUTHOR

Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.

AUTHORS

Disclosures: Lindy Liu, MPH; Laura S. Callinan; Robert C. Holman, MS; and Dianna M. Blau, DVM, PhD, have disclosed no relevant financial relationships.

Top

Abstract

We analyzed US multiple cause-of-death data for 2003–2006 for demographic and clinical determinants for autopsy in unexplained deaths possibly resulting from infectious causes. For 96,242 deaths, the definition for unexplained death was met and autopsy status was recorded. Most decedents were male, 40–49 years of age, and white. To identify factors associated with unexplained death, we used data from Arizona records. Multivariate analysis of Arizona records suggested that decedents of races other than white and black and decedents who had clinicopathologic syndromes in the cardiovascular, sepsis/shock, and multisyndrome categories recorded on the death certificate were least likely to have undergone autopsy; children with unexplained death were the most likely to have undergone autopsy. Improved understanding of unexplained deaths can provide opportunities for further studies, strengthen collaboration between investigators of unexplained deaths, and improve knowledge and awareness of infectious diseases of public health concern.

Many factors can influence the dynamics of pathogen ecology, increase the mobility of microbial agents, and elevate the risk for infectious disease posed to humans. Outbreaks and novel pathogens identified in recent decades are reminders that historical and newly recognized infectious diseases remain threats to the health of the global community (13). Unexplained deaths possibly resulting from infectious causes (unexplained deaths) also present public health challenges. Many fatal infectious etiologies are never identified because of inadequate testing or inherent difficulties of detecting certain pathogens (4).

An autopsy can verify an existing diagnosis or provide a diagnosis if one is not determined before death, which might facilitate provision of prophylaxis or treatment of contacts of decedents with communicable diseases. Autopsies also contribute to epidemiologic data, provide insights into disease pathogenesis, and create educational opportunities for physicians and medical students (5). Recent disease descriptions facilitated by autopsy findings include hantavirus pulmonary syndrome, West Nile virus, and severe acute respiratory syndrome (SARS) (68); pathogens for these diseases were recognized only after substantial numbers of illnesses and deaths. Although autopsies of persons who died of unexplained causes can help build public health capacity to respond to emerging infectious diseases, the declining rate of autopsies performed in US hospitals reduces the possibility of early detection of such diseases (9). Because most autopsies in the United States are now performed by medical examiners and coroners (10), medicolegal death investigation system–based surveillance for unexplained death can serve as a sentinel system to identify new agents, recognize unique characteristics of known pathogens, or detect acts of bioterrorism (11). Medical examiner and coroner systems contribute to national mortality data and autopsy-based information (12), and specimens collected at autopsy of persons whose deaths are unexplained could lead to diagnoses from advancements in diagnostic methods that have enabled identification and characterization of new infectious agents.

Although an earlier study measured unexplained deaths and critical illnesses (4), the demographic characteristics and clinicopathologic syndromes of persons whose deaths are unexplained who undergo autopsies have not been described. Understanding the types of persons who died of unexplained causes and who undergo autopsies might help identify specimens for diagnostic testing and improve epidemiologic and mortality data. We analyzed demographic characteristics and infectious disease–related syndromes associated with unexplained death in decedents for whom an autopsy was performed in the United States.

Methods

Data Source and Study Population

We obtained multiple cause-of-death data with autopsy status for 2003–2006 in the 50 states and the District of Columbia from the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (13). Multiple cause-of-death data contain information from all death certificates for US residents, including demographic information and causes of death that have been translated to International Classification of Diseases, 10th Revision (ICD-10), codes (14).

On the basis of the previous definition of unexplained death (15) that was refined to use ICD-10 codes, we used 99 codes likely to represent deaths from unexplained infectious causes to select decedents for this study (Table A1). These codes aimed to capture deaths from infectious causes that lacked an identifiable etiologic agent or deaths with unknown causes. Unexplained deaths were defined as deaths of previously healthy US residents 1–49 years of age for whom the death certificate had >1 codes for unexplained infections. Decedents with unexplained infections for whom any of the ICD-10 codes listed in the Table 1 as an underlying cause of death were not considered previously healthy and were excluded from analysis. Decedents outside the age range also were excluded. We excluded infants (<1 year of age) to eliminate deaths attributed to congenital problems and persons >50 years of age because of the expected increased proportion of unexplained deaths from noninfectious causes (15). Analyses were restricted to unexplained deaths for which we could ascertain from the selected death certificate data whether an autopsy had been performed.

Study Measures and Statistical Analysis

Decedents were described by age, sex, and race and by the syndromic category recorded on the death certificate. Age was categorized as 1–17 years (children), 18–39 years, and 40–49 years. Race categories were white, black, and other, as recorded on death certificates and obtained from NCHS (13). Death certificates enabled reporting of >1 race, including any combination of white, black or African American, American Indian or Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander, and decedents were imputed to a single race according to their combination of races, Hispanic origin, sex, and age indicated on the death certificate (16). On the basis of the selected ICD-10 codes, unexplained deaths were also grouped into 6 clinicopathologic syndromes: gastrointestinal, neurologic, respiratory, cardiovascular, sepsis/shock, and unknown/other (Table 2). Unexplained deaths for which ICD-10 codes were recorded as belonging to >2 syndromic categories were classified as multisyndrome.

We calculated odds ratios (ORs) with 95% CIs for selected characteristics by using logistic regression analysis. Characteristics considered univariately associated (p<0.1) with autopsy were further assessed through multivariate logistic regression models to determine which variables were independently associated with autopsy. We considered p<0.05 as significant. Because of the large sample size, statistical but not meaningful significance was found for most variables in the logistic regression model, including all unexplained deaths during 2003–2006 (data not shown). To further evaluate the variables, we created a multivariate logistic regression model using unexplained death data from Arizona for 2003–2006 (17). This subset of data was selected because of the minimal amount of missing autopsy data (0.2%) and the Unexplained Deaths Investigation Protocol, which identifies deaths that might be of public health concern, established by the Arizona Department of Health Services (18).

Results

United States

A total of 153,476 deaths were reported for persons 1–49 years of age for whom the selected ICD-10 codes (Table A1) were recorded in the multiple cause-of-death data for 2003–2006. Of these, 111,160 (72.4%) met the definition for unexplained death, and information on autopsy status was available for 96,242 (86.6%). Of decedents for whom autopsy status was known, 38,332 (39.8%) had undergone autopsy.

Of decedents for whom autopsy status was known, 59.5% were male (Table 3). Most decedents whose deaths were unexplained (55.1%) were 40–49 years of age; children accounted for 9.2%. Whites composed 71.7% of unexplained deaths, followed by blacks (24.6%) and others (3.7%). For most unexplained deaths, cause was coded as unknown/other syndrome (33.1%). Sepsis/shock accounted for 21.6%, and gastrointestinal and neurologic causes accounted for only 1.8% each.

More male than female decedents underwent autopsies (41.5% vs. 37.4%) (Table 3). The highest percentage of autopsies was performed for white decedents (40.7%); autopsies were performed for 38.1% of black decedents and 34.0% of other decedents. Children whose deaths were unexplained underwent the highest percentage of autopsies (50.5%), followed by persons 18–39 years (48.4%) and 40–49 years of age (32.5%). The highest percentage of autopsies were performed on decedents whose cause of death was coded as unknown/other syndrome (65.3%); the lowest percentage of autopsies were performed on decedents whose deaths were coded as sepsis/shock syndrome (15.9%).

Arizona

Of the 2,097 persons in Arizona who died from unexplained possibly infectious causes and for whom autopsy status was known, most (55.2%) were 40–49 years of age (Table 4). Whites composed 78.6% of such decedents, followed by others (14.4%) and blacks (7.1%). Most (33.9%) unexplained deaths resulted from other/unknown causes; unexplained deaths from gastrointestinal causes accounted for 1.2%.

Percentages of decedents for whom an autopsy was performed were similar for whites (35.2%) and blacks (35.8%) (Table 4). The highest percentages of autopsies were performed on children whose deaths were unexplained (44.5%), followed by persons 18–39 years (38.0%) and 40–49 (28.1%) years of age. Of the 7 syndromic classifications, gastrointestinal cause of death accounted for the highest percentage of autopsies (60.0%) and sepsis/shock for the lowest percentage (14.5%).

Univariate analysis of data on persons who died from unexplained infectious causes in Arizona indicated that race, age group, and syndromic category, but not sex, were significantly associated with autopsy. Multivariate logistic regression analysis indicated that race, age group, and syndromic category remained independent predictors of autopsy. Persons of other races were less likely than white persons to undergo autopsy (OR 0.5, 95% CI 0.4–0.7) (Table 4). Children whose deaths were unexplained (OR 1.9, 95% CI 1.4–2.6) and persons 18–39 years of age (OR 1.6, 95% CI 1.3–2.0) were more likely to have undergone autopsy than were persons 40–49 years of age (Table 4). Persons with cardiovascular conditions, sepsis/shock, and multisyndrome conditions were less likely to have undergone autopsy than were persons with unknown/other unexplained deaths (Table 4).

Discussion

Unlike other studies that have described and analyzed characteristics that influence autopsies overall (19,20), ours describes demographic characteristics and clinicopathologic syndromes associated with autopsy of persons who died of unexplained infectious causes in the United States. The overall percentage of autopsies performed on such decedents during 2003–2006 (39.8%) was higher than estimates of the proportion of overall autopsies in the United States (≈8.5%) (21). The higher percentage of autopsies for persons whose deaths were unexplained might reflect the frequent inclusion of complete autopsies in investigations of natural disease deaths by medical examiners and coroners (22).

Our finding that most characteristics in the multivariate regression analysis were highly significant when complete data for 2003–2006 were included in the analysis probably resulted from the large number of persons in the study whose deaths were unexplained. Unexplained deaths among persons with a history of fever have been reportable in Arizona since 2004, and medical examiners and health care providers are required to report unexplained infectious deaths to their local health departments (18). The Arizona Unexplained Deaths Investigation Protocol identifies appropriate specimens and clinical data needed for investigation, and the Arizona data might elucidate true demographic characteristics and syndromic trends of unexplained deaths in the United States. The analysis of data for Arizona decedents suggests that race, age, and clinicopathologic syndrome are potentially major factors for whether persons who died of unexplained infectious causes undergo autopsy.

Data on religious preferences are not collected on death certificates, but race might have been a proxy for cultural and religious preferences. Religious objections and lack of understanding about cultural or religious influences have been reported as reasons a family might not consent to an autopsy (23,24). For example, many American Indian tribes have traditions contrary to autopsy in which organ specimens are retained by medical examiners and pathologists (25). The observed lower odds for autopsy of decedents of other races possibly resulted from the larger American Indian population in Arizona (5%) than in the United States (1%) (26).

Results from the analysis of the Arizona subset suggest that children and young adults whose deaths resulted from unexplained possibly infectious causes are more likely than older adults to have undergone autopsies. Although some studies have suggested that children are more likely to undergo autopsies (19,20), the literature regarding the association between age and autopsy is limited, and findings have been inconclusive (27,28). Particularly when children die suddenly or unexpectedly, which is often from infectious causes (29), autopsies can contribute to families’ understanding of the circumstances of death or expand medical knowledge (19,30).

Persons whose unexplained deaths were coded as from cardiovascular, sepsis/shock, or multisyndrome causes were less likely than those whose deaths were coded as unknown/other to undergo autopsies. These results could reflect differences in the availability and resources of investigators of unexplained deaths from possibly infectious causes. Sepsis, in particular, remains perplexing and costly, and despite efforts to understand the systemic inflammation and multisystem organ failure characteristics of severe sepsis, the reason many of these patients die remains unknown (31,32). Furthermore, investigators of unexplained deaths or family members of decedents might have believed that additional studies, including autopsy, would not yield substantial findings. According to an opinion survey of pathology and medicine resident physicians, reasons families refuse autopsies included beliefs that the patient has suffered enough and that the autopsy would not be useful (33). Routine microscopic examination has been argued to not provide additional information in forensic pathology cases for which the cause and manner of death are apparent at the time of autopsy (34). However, the reduced likelihood of autopsy or further evaluation of these challenging unexplained deaths could also result in the failure to recognize infectious diseases. For example, Chong et al. illustrated the difficulty of differentiating an emerging disease (SARS) from other causes of sudden cardiovascular death at autopsy (35). Of the14 autopsies performed on persons with suspected or probable SARS, 8 confirmed SARS only on the basis of clinical history, histopathologic evaluation, and testing of autopsy specimens. Therefore, an autopsy should be pursued especially for those whose unexplained deaths were possibly of infectious causes.

Reasons for differences in likelihood of autopsy with respect to race, age, and clinicopathologic syndrome could be multifactorial, and results from our study are subject to limitations. The availability, training, and resources of investigators of unexplained natural deaths differ among institutions and jurisdictions and might account for differences in autopsy performance, testing capabilities, and reporting of autopsy data (12,36). Unfortunately, multiple cause-of-death data do not capture whether autopsies are performed by medical examiners or by hospital-based pathologists, and differences in autopsy rates between medicolegal death investigation systems and hospital-based pathologists in unexplained death remains unknown. Inaccuracy in death certification and reliance solely on ICD-10 classification for unexplained death also has limitations. Codes might be assigned by persons not directly familiar with decedents and who therefore might not be aware of known diagnoses. Death certificates might not have been amended when organism-specific etiologies (i.e., Streptococcus pneumoniae) were determined after broad ICD-10 codes (i.e., bacterial meningitis) were assigned. Results from our study also are limited by the restriction of analyses to unexplained deaths for which autopsy status is known and the large variation of autopsy data reported by states to NCHS. Of deaths that met the unexplained death definition, the percentage of missing autopsy status data by state ranged from 0 to 99% during 2003–2006. Additional data on autopsy status reported to NCHS could have more accurately described unexplained death.

Additional studies are needed to assess the similarities in demographic characteristics and clinicopathologic syndromes of persons who died of unexplained possibly infectious causes and characteristics found in autopsies overall. The statistically significant findings of such characteristics as age and race in this study could reflect general trends of autopsies performed and might not be unique to persons whose infectious deaths are unexplained. Furthermore, results from the analysis of Arizona data might not necessarily reflect unexplained deaths in other states or nationally.

Additional insight into persons who died of unexplained infectious causes and underwent autopsies might help pinpoint areas in which diagnostic capabilities or resources are needed (15) and provide opportunities for additional studies. Retrospective studies using postmortem specimens and improved diagnostic tools could benefit the broader community. Improved understanding by health departments and medical examiners of a specific type of unexplained death for which an autopsy is conducted could increase overall awareness of unexplained deaths from infectious causes; improve approaches in the collection of medical history and laboratory results in the forensic setting (37); and strengthen collaboration between health departments, clinicians, and medical examiners. Awareness of the types of unexplained death for which autopsies are less likely to be conducted is also imperative. Clinicians and pathologists challenged by cultural or religious restrictions can consider alternative methods for diagnosis such as taking biopsy samples (38), collecting appropriate antemortem specimens, or performing virtual autopsies (39,40). Retrospective studies evaluating perceptions by families, physicians, and medical examiners on autopsies of persons who died of unexplained infectious causes also might be helpful. Improving education about unexplained death and autopsy, identifying areas where diagnostic resources are needed, and maintaining cooperation between investigators should be considered. Autopsy findings, in conjunction with clinical history and diagnostic tools, can assist surveillance and investigations of infectious diseases of public health concern.

Ms Liu is an epidemiologist at the Infectious Diseases Pathology Branch, US Centers for Disease Control and Prevention. Her research interests include infectious disease epidemiology and the role of pathology in investigating unexplained deaths resulting from infectious causes.

Top

Acknowledgment

We thank Amy Denison, Christopher Paddock, and Sherif Zaki for their helpful discussion and critical review of this article.

Top

References

  1. Campbell  GL, Hughes  JM. Plague in India: a new warning from an old nemesis. Ann Intern Med. 1995;122:1513.PubMedGoogle Scholar
  2. Fischer  SA, Graham  MB, Kuehnert  MJ, Kotton  CN, Srinivasan  A, Marty  FM, Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med. 2006;354:223549. DOIPubMedGoogle Scholar
  3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team; Dawood  FS, Jain  S, Finelli  L, Shaw  MW, Lindstrom  S, Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:260515. DOIPubMedGoogle Scholar
  4. Hajjeh  RA, Relman  D, Cieslak  PR, Sofair  AN, Passaro  D, Flood  J, Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995–1998. Emerg Infect Dis. 2002;8:14553. DOIPubMedGoogle Scholar
  5. McPhee  SJ. Maximizing the benefits of autopsy for clinicians and families. What needs to be done. Arch Pathol Lab Med. 1996;120:7438.PubMedGoogle Scholar
  6. Zaki  SR, Greer  PW, Coffield  LM, Goldsmith  CS, Nolte  KB, Foucar  K, Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol. 1995;146:55279.PubMedGoogle Scholar
  7. Shieh  WJ, Guarner  J, Layton  M, Fine  A, Miller  J, Nash  D, The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis. 2000;6:3702. DOIPubMedGoogle Scholar
  8. Nicholls  JM, Poon  LL, Lee  KC, Ng  WF, Lai  ST, Leung  CY, Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:17738. DOIPubMedGoogle Scholar
  9. Dalen  JE. The moribund autopsy. DNR or CPR? Arch Intern Med. 1997;157:1633. DOIPubMedGoogle Scholar
  10. Hanzlick  R. Medical examiners, coroners, and public health: a review and update. Arch Pathol Lab Med. 2006;130:127482.PubMedGoogle Scholar
  11. Nolte  KB, Fischer  M, Reagan  S, Lynfield  R. Guidelines to implement medical examiner/coroner-based surveillance for fatal infectious diseases and bioterrorism (“Med-X”). Am J Forensic Med Pathol. 2010;31:30812. DOIPubMedGoogle Scholar
  12. Hanzlick  R. The conversion of coroner systems to medical examiner systems in the United States: a lull in the action. Am J Forensic Med Pathol. 2007;28:27983. DOIPubMedGoogle Scholar
  13. National Center for Health Statistics. Vital statistics mortality data, multiple cause detail, 2003–2006. Public use data tape contents and documentation package. Hyattsville (MD): The Center; 2008.
  14. Centers for Disease Control and Prevention. Multiple cause of death 1999−2006 [cited 2011 Nov 15]. http://wonder.cdc.gov/wonder/help/mcd.html
  15. Perkins  BA, Flood  JM, Danila  R, Holman  RC, Reingold  AL, Klug  LA, Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. Emerg Infect Dis. 1996;2:4753. DOIPubMedGoogle Scholar
  16. Ingram  DD, Parker  JD, Schenker  N, Weed  JA, Hamilton  B, Arias  E, United States Census 2000 population with bridged race categories. Vital Health Stat 2. 2003;(135):155.PubMedGoogle Scholar
  17. Kleinbaum  D, Klein  M. Logisitc regression: a self-learning text. 2nd ed. New York: Springer-Verlag; 2002.
  18. Arizona Department of Health Services, Infectious Disease Epidemiology Program. Unexplained deaths with history of fever (UNEX) [cited 2011 Nov 15]. http://www.azdhs.gov/phs/oids/epi/unex/index.htm
  19. Sinard  JH. Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol. 2001;70:33343. DOIPubMedGoogle Scholar
  20. Andrews-Joseph  A, Bourgeois  SS, Ratard  RC. Louisiana autopsy patterns 1999–2006. J La State Med Soc. 2009;161(2):97, 99–102. PubMedGoogle Scholar
  21. Hoyert  DL. The changing profile of autopsied deaths in the United States, 1972–2007. NCHS data brief. No. 67, August 2011. Hyattsville (MD): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2011 [cited 2011 Nov 15]. http://www.cdc.gov/nchs/data/databriefs/db67.htm
  22. Wolfe  MI, Nolte  KB, Yoon  SS. Fatal infectious disease surveillance in a medical examiner database. Emerg Infect Dis. 2004;10:4853.PubMedGoogle Scholar
  23. Geller  SA. Religious attitudes and the autopsy. Arch Pathol Lab Med. 1984;108:4946.PubMedGoogle Scholar
  24. Perkins  HS, Supik  JD, Hazuda  HP. Autopsy decisions: the possibility of conflicting cultural attitudes. J Clin Ethics. 1993;4:14554.PubMedGoogle Scholar
  25. Krinsky  CS, Lathrop  SL, Reichard  RR. A policy for the retention and extended examination of organs at autopsy. J Forensic Sci. 2010;55:41822. DOIPubMedGoogle Scholar
  26. US Census Bureau. State and county quick facts: Arizona [cited 2011 Nov 15]. http://quickfacts.census.gov/qfd/states/04000.html
  27. Whitehouse  SR, Kissoon  N, Singh  N, Warren  D. The utility of autopsies in a pediatric emergency department. Pediatr Emerg Care. 1994;10:725. DOIPubMedGoogle Scholar
  28. Ahronheim  JC, Bernholc  AS, Clark  WD. Age trends in autopsy rates. Striking decline in late life. JAMA. 1983;250:11826. DOIPubMedGoogle Scholar
  29. Taggart  MW, Craver  R. Causes of death, determined by autopsy, in previously healthy (or near-healthy) children presenting to a children’s hospital. Arch Pathol Lab Med. 2006;130:17805.PubMedGoogle Scholar
  30. Beckwith  JB. The value of the pediatric postmortem examination. Pediatr Clin North Am. 1989;36:2936.PubMedGoogle Scholar
  31. Angus  DC, Linde-Zwirble  WT, Lidicker  J, Clermont  G, Carcillo  J, Pinsky  MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:130310. DOIPubMedGoogle Scholar
  32. Torgersen  C, Moser  P, Luckner  G, Mayr  V, Jochberger  S, Hasibeder  WR, Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg. 2009;108:18417. DOIPubMedGoogle Scholar
  33. Hull  MJ, Nazarian  RM, Wheeler  AE, Black-Schaffer  WS, Mark  EJ. Resident physician opinions on autopsy importance and procurement. Hum Pathol. 2007;38:34250. DOIPubMedGoogle Scholar
  34. Molina  DK, Wood  LE, Frost  RE. Is routine histopathologic examination beneficial in all medicolegal autopsies? Am J Forensic Med Pathol. 2007;28:13. DOIPubMedGoogle Scholar
  35. Chong  PY, Chui  P, Ling  AE, Franks  TJ, Tai  DY, Leo  YS, Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med. 2004;128:195204.PubMedGoogle Scholar
  36. Wilson  ML, Gradus  S, Zimmerman  SJ. The role of local public health laboratories. Public Health Rep. 2010;125(Suppl 2):11822.PubMedGoogle Scholar
  37. Christiansen  LR, Collins  KA. Natural death in the forensic setting: a study and approach to the autopsy. Am J Forensic Med Pathol. 2007;28:203. DOIPubMedGoogle Scholar
  38. Huston  BM, Malouf  NN, Azar  HA. Percutaneous needle autopsy sampling. Mod Pathol. 1996;9:11017.PubMedGoogle Scholar
  39. Thali  MJ, Yen  K, Schweitzer  W, Vock  P, Boesch  C, Ozdoba  C, Virtopsy, a new imaging horizon in forensic pathology: virtual autopsy by postmortem multislice computed tomography (MSCT) and magnetic resonance imaging (MRI)—a feasibility study. J Forensic Sci. 2003;48:386403.PubMedGoogle Scholar
  40. Thali  MJ, Dirnhofer  R, Becker  R, Oliver  W, Potter  K. Is ‘virtual histology’ the next step after the ‘virtual autopsy’? Magnetic resonance microscopy in forensic medicine. Magn Reson Imaging. 2004;22:11318. DOIPubMedGoogle Scholar

Top

Tables

Top

Follow Up

Earning CME Credit

To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and earn continuing medical education (CME) credit, please go to www.medscape.org/journal/eid. Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You must be a registered user on Medscape.org. If you are not registered on Medscape.org, please click on the New Users: Free Registration link on the left hand side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@webmd.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to http://www.ama-assn.org/ama/pub/category/2922.html. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the certificate and present it to your national medical association for review.

Article Title: Determinants for Autopsy after Unexplained Deaths Possibly Resulting from Infectious Causes, United States

CME Questions

1. You are part of a county task force charged with developing means to monitor emerging infections, and you are preparing for a discussion of unexplained deaths possibly resulting from infectious causes (UDPIC).

In the current study, what was a significant characteristic of cases of UDPIC?

A.        Most cases occurred among male patients

B.         Most cases occurred among children

C.        Most cases occurred among persons of black race

D.        Most cases occurred among persons of races other than black or white

2. Which of the following was the most common category of UDPIC from the national sample in the current study?

A.        Sepsis/shock

B.         Gastrointestinal disease

C.        Neurologic disease

D.        Unknown/other syndrome

3. Which of the following age groups was most likely to have received an autopsy in the current study of UDPIC?

A.        Children and adolescents under age 18 years

B.         Adults age 18–39 years

C.        Adults age 40–49 years

D.        Adults age 50 or older

4. What other characteristic was most associated with receiving an autopsy in the current study?

A.        UDPIC due to sepsis/shock

B.         Living in an urban center

C.        White race

D.        Race other than white or black

Activity Evaluation

1. The activity supported the learning objectives.

Strongly Disagree

Strongly Agree

1

2

3

4

5

2. The material was organized clearly for learning to occur.

Strongly Disagree

Strongly Agree

1

2

3

4

5

3. The content learned from this activity will impact my practice.

Strongly Disagree

Strongly Agree

1

2

3

4

5

4. The activity was presented objectively and free of commercial bias.

Strongly Disagree

Strongly Agree

1

2

3

4

5

Top

Cite This Article

DOI: 10.3201/eid1804.111311

Related Links

Table of Contents – Volume 18, Number 4—April 2012

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Lindy Liu, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G32, Atlanta, GA 30333, USA

Send To

10000 character(s) remaining.

Top

Page created: March 16, 2012
Page updated: March 16, 2012
Page reviewed: March 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external